165 companies
Infinity Natural Resources
Market Cap: US$1.0b
Engages in the acquisition, exploration, and development of properties to produce crude oil, natural gas, and natural gas liquids in the United States.
INR
US$16.26
7D
0.9%
1Y
5.9%
AVITA Medical
Market Cap: US$129.9m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$4.23
7D
-2.3%
1Y
-54.7%
Travere Therapeutics
Market Cap: US$3.7b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$40.10
7D
-1.8%
1Y
93.2%
Zevra Therapeutics
Market Cap: US$571.3m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$9.67
7D
-4.4%
1Y
26.6%
Madrigal Pharmaceuticals
Market Cap: US$11.9b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$518.58
7D
-0.03%
1Y
58.2%
Syndax Pharmaceuticals
Market Cap: US$1.8b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$20.63
7D
-1.8%
1Y
49.3%
T1 Energy
Market Cap: US$1.4b
Provides energy solutions for solar modules and cells in the United States, Norway and internationally.
TE
US$4.89
7D
-9.3%
1Y
304.1%
Ardelyx
Market Cap: US$1.5b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$6.01
7D
0.8%
1Y
9.9%
AnaptysBio
Market Cap: US$1.8b
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.
ANAB
US$62.34
7D
21.6%
1Y
187.3%
WaterBridge Infrastructure
Market Cap: US$3.5b
WaterBridge Infrastructure LLC, water infrastructure company, provides water management solutions through integrated pipeline and water handling networks in the United States.
WBI
US$29.81
7D
7.1%
1Y
n/a
AGI
Market Cap: US$1.2b
Provides technology-based specialized financial services in Brazil.
AGBK
US$7.39
7D
0.8%
1Y
n/a
Alignment Healthcare
Market Cap: US$4.4b
Operates a consumer-centric healthcare platform for seniors in the United States.
ALHC
US$21.72
7D
4.3%
1Y
29.5%
Oracle
Market Cap: US$477.3b
Offers products and services that address enterprise information technology environments worldwide.
ORCL
US$163.83
7D
-12.6%
1Y
16.4%
Caledonia Mining
Market Cap: US$441.3m
Primarily operates a gold mine in Jersey.
CMCL
US$22.59
7D
-8.4%
1Y
71.5%
FTAI Aviation
Market Cap: US$21.9b
Owns, acquires, and sells aviation equipment for the transportation of goods and people worldwide.
FTAI
US$213.11
7D
-9.5%
1Y
145.2%
Abeona Therapeutics
Market Cap: US$304.9m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$5.34
7D
-5.2%
1Y
-18.6%
Compass
Market Cap: US$5.9b
Provides an end-to-end technology platform for residential real estate in the United States.
COMP
US$7.62
7D
-3.7%
1Y
-1.3%
Luckin Coffee
Market Cap: US$10.0b
Offers retail services of freshly brewed drinks, and pre-made food and beverage items in the People's Republic of China.
LKNC.Y
US$36.00
7D
10.8%
1Y
12.4%
Pelthos Therapeutics
Market Cap: US$83.8m
A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
PTHS
US$25.09
7D
9.1%
1Y
120.1%
CVB Financial
Market Cap: US$2.7b
Operates as bank holding company for Citizens Business Bank, National Association, a state-chartered bank that provides banking and financial services to small to mid-sized businesses and individuals.
CVBF
US$20.24
7D
0.1%
1Y
7.9%
UroGen Pharma
Market Cap: US$1.1b
A biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$23.34
7D
-4.0%
1Y
104.6%
Aldeyra Therapeutics
Market Cap: US$91.5m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
ALDX
US$1.50
7D
-6.3%
1Y
-44.6%
SM Energy
Market Cap: US$7.0b
An independent energy company, engages in the acquisition, exploration, development, and production of oil, gas, and natural gas liquids in the United States.
SM
US$31.23
7D
7.5%
1Y
37.0%
Pagaya Technologies
Market Cap: US$1.1b
A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services, their customers, and institutional or sophisticated investors in the United States, Israel, and the Cayman Islands.
PGY
US$12.92
7D
-11.1%
1Y
17.8%
ARS Pharmaceuticals
Market Cap: US$778.0m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.
SPRY
US$7.84
7D
-5.5%
1Y
-44.6%
Capricor Therapeutics
Market Cap: US$1.9b
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$32.46
7D
-4.1%
1Y
154.8%
Nutanix
Market Cap: US$11.0b
Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.
NTNX
US$42.00
7D
1.3%
1Y
-38.9%
Daqo New Energy
Market Cap: US$1.5b
Manufactures and sells polysilicon to photovoltaic product manufacturers in the People’s Republic of China.
DQ
US$19.35
7D
-16.7%
1Y
51.9%
Simmons First National
Market Cap: US$3.1b
Operates as the bank holding company for Simmons Bank that provides banking and other financial products and services to individuals and businesses.
SFNC
US$21.25
7D
0.4%
1Y
13.9%
Bitgo Holdings
Market Cap: US$1.2b
Operates as a digital asset infrastructure company in the United States and internationally.
BTGO
US$9.70
7D
-17.0%
1Y
n/a
Arcutis Biotherapeutics
Market Cap: US$2.8b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$22.37
7D
-2.1%
1Y
52.7%
CG Oncology
Market Cap: US$5.5b
A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.
CGON
US$64.75
7D
-7.4%
1Y
133.4%
Intapp
Market Cap: US$1.9b
Through its subsidiary, Integration Appliance, Inc., provides AI-powered solutions in the United States, the United Kingdom, and internationally.
INTA
US$23.20
7D
6.8%
1Y
-58.2%
Gossamer Bio
Market Cap: US$80.7m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.
GOSS
US$0.35
7D
-6.4%
1Y
-67.0%
Atlassian
Market Cap: US$18.6b
Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.
TEAM
US$70.49
7D
4.2%
1Y
-69.2%
Elastic
Market Cap: US$4.9b
A search artificial intelligence (AI) company, provides software platforms to run in hybrid, public or private clouds, and multi-cloud environments in the United States and internationally.
ESTC
US$47.40
7D
-3.7%
1Y
-45.0%